 | • レポートコード：QYR2104Z3305 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、若年性特発性関節炎治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（外科的治療、薬物治療）、用途別市場規模（病院、クリニック、診断研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・若年性特発性関節炎治療の市場動向 ・企業の競争状況、市場シェア ・若年性特発性関節炎治療の種類別市場規模（外科的治療、薬物治療） ・若年性特発性関節炎治療の用途別市場規模（病院、クリニック、診断研究所） ・若年性特発性関節炎治療の北米市場規模2016-2027（アメリカ、カナダ） ・若年性特発性関節炎治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・若年性特発性関節炎治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・若年性特発性関節炎治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・若年性特発性関節炎治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Johnson & Johnson、Novartis、Bristol-Myers Squibb、Zydus Cadila、Takeda、Roche、Latona Life Sciences） ・結論 |
Arthritis is a very common disease but it is not well understood yet. Arthritis is basically joint pain or joint disease. Basically Juvenile idiopathic arthritis or juvenile rheumatoid arthritis is the common inflammatory arthritis of childhood and Common symptom of Juvenile idiopathic arthritis is musculoskeletal pain. Juvenile idiopathic arthritis is mostly affected to under age 17 children.
Market Analysis and Insights: Global Juvenile Idiopathic Arthritis Treatment Market
The global Juvenile Idiopathic Arthritis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Juvenile Idiopathic Arthritis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Juvenile Idiopathic Arthritis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Juvenile Idiopathic Arthritis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Juvenile Idiopathic Arthritis Treatment market.
Global Juvenile Idiopathic Arthritis Treatment Scope and Market Size
Juvenile Idiopathic Arthritis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Juvenile Idiopathic Arthritis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Surgical Treatment
Drug Treatment
Segment by Application
Hospital
Clinic
Diagnostic Laboratories
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Johnson & Johnson
Novartis
Bristol-Myers Squibb
Zydus Cadila
Takeda
Roche
Latona Life Sciences
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Juvenile Idiopathic Arthritis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Surgical Treatment
1.2.3 Drug Treatment
1.3 Market by Application
1.3.1 Global Juvenile Idiopathic Arthritis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Diagnostic Laboratories
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Juvenile Idiopathic Arthritis Treatment Market Perspective (2016-2027)
2.2 Juvenile Idiopathic Arthritis Treatment Growth Trends by Regions
2.2.1 Juvenile Idiopathic Arthritis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Juvenile Idiopathic Arthritis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Juvenile Idiopathic Arthritis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Juvenile Idiopathic Arthritis Treatment Industry Dynamic
2.3.1 Juvenile Idiopathic Arthritis Treatment Market Trends
2.3.2 Juvenile Idiopathic Arthritis Treatment Market Drivers
2.3.3 Juvenile Idiopathic Arthritis Treatment Market Challenges
2.3.4 Juvenile Idiopathic Arthritis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Juvenile Idiopathic Arthritis Treatment Players by Revenue
3.1.1 Global Top Juvenile Idiopathic Arthritis Treatment Players by Revenue (2016-2021)
3.1.2 Global Juvenile Idiopathic Arthritis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Juvenile Idiopathic Arthritis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Juvenile Idiopathic Arthritis Treatment Revenue
3.4 Global Juvenile Idiopathic Arthritis Treatment Market Concentration Ratio
3.4.1 Global Juvenile Idiopathic Arthritis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Juvenile Idiopathic Arthritis Treatment Revenue in 2020
3.5 Juvenile Idiopathic Arthritis Treatment Key Players Head office and Area Served
3.6 Key Players Juvenile Idiopathic Arthritis Treatment Product Solution and Service
3.7 Date of Enter into Juvenile Idiopathic Arthritis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Juvenile Idiopathic Arthritis Treatment Breakdown Data by Type
4.1 Global Juvenile Idiopathic Arthritis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Juvenile Idiopathic Arthritis Treatment Forecasted Market Size by Type (2022-2027)
5 Juvenile Idiopathic Arthritis Treatment Breakdown Data by Application
5.1 Global Juvenile Idiopathic Arthritis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Juvenile Idiopathic Arthritis Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Juvenile Idiopathic Arthritis Treatment Market Size (2016-2027)
6.2 North America Juvenile Idiopathic Arthritis Treatment Market Size by Type
6.2.1 North America Juvenile Idiopathic Arthritis Treatment Market Size by Type (2016-2021)
6.2.2 North America Juvenile Idiopathic Arthritis Treatment Market Size by Type (2022-2027)
6.2.3 North America Juvenile Idiopathic Arthritis Treatment Market Size by Type (2016-2027)
6.3 North America Juvenile Idiopathic Arthritis Treatment Market Size by Application
6.3.1 North America Juvenile Idiopathic Arthritis Treatment Market Size by Application (2016-2021)
6.3.2 North America Juvenile Idiopathic Arthritis Treatment Market Size by Application (2022-2027)
6.3.3 North America Juvenile Idiopathic Arthritis Treatment Market Size by Application (2016-2027)
6.4 North America Juvenile Idiopathic Arthritis Treatment Market Size by Country
6.4.1 North America Juvenile Idiopathic Arthritis Treatment Market Size by Country (2016-2021)
6.4.2 North America Juvenile Idiopathic Arthritis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Juvenile Idiopathic Arthritis Treatment Market Size (2016-2027)
7.2 Europe Juvenile Idiopathic Arthritis Treatment Market Size by Type
7.2.1 Europe Juvenile Idiopathic Arthritis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Juvenile Idiopathic Arthritis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Juvenile Idiopathic Arthritis Treatment Market Size by Type (2016-2027)
7.3 Europe Juvenile Idiopathic Arthritis Treatment Market Size by Application
7.3.1 Europe Juvenile Idiopathic Arthritis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Juvenile Idiopathic Arthritis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Juvenile Idiopathic Arthritis Treatment Market Size by Application (2016-2027)
7.4 Europe Juvenile Idiopathic Arthritis Treatment Market Size by Country
7.4.1 Europe Juvenile Idiopathic Arthritis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Juvenile Idiopathic Arthritis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Juvenile Idiopathic Arthritis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Juvenile Idiopathic Arthritis Treatment Market Size by Type
8.2.1 Asia-Pacific Juvenile Idiopathic Arthritis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Juvenile Idiopathic Arthritis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Juvenile Idiopathic Arthritis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Juvenile Idiopathic Arthritis Treatment Market Size by Application
8.3.1 Asia-Pacific Juvenile Idiopathic Arthritis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Juvenile Idiopathic Arthritis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Juvenile Idiopathic Arthritis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Juvenile Idiopathic Arthritis Treatment Market Size by Region
8.4.1 Asia-Pacific Juvenile Idiopathic Arthritis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Juvenile Idiopathic Arthritis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Juvenile Idiopathic Arthritis Treatment Market Size (2016-2027)
9.2 Latin America Juvenile Idiopathic Arthritis Treatment Market Size by Type
9.2.1 Latin America Juvenile Idiopathic Arthritis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Juvenile Idiopathic Arthritis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Juvenile Idiopathic Arthritis Treatment Market Size by Type (2016-2027)
9.3 Latin America Juvenile Idiopathic Arthritis Treatment Market Size by Application
9.3.1 Latin America Juvenile Idiopathic Arthritis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Juvenile Idiopathic Arthritis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Juvenile Idiopathic Arthritis Treatment Market Size by Application (2016-2027)
9.4 Latin America Juvenile Idiopathic Arthritis Treatment Market Size by Country
9.4.1 Latin America Juvenile Idiopathic Arthritis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Juvenile Idiopathic Arthritis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Juvenile Idiopathic Arthritis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Juvenile Idiopathic Arthritis Treatment Market Size by Type
10.2.1 Middle East & Africa Juvenile Idiopathic Arthritis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Juvenile Idiopathic Arthritis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Juvenile Idiopathic Arthritis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Juvenile Idiopathic Arthritis Treatment Market Size by Application
10.3.1 Middle East & Africa Juvenile Idiopathic Arthritis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Juvenile Idiopathic Arthritis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Juvenile Idiopathic Arthritis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Juvenile Idiopathic Arthritis Treatment Market Size by Country
10.4.1 Middle East & Africa Juvenile Idiopathic Arthritis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Juvenile Idiopathic Arthritis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Juvenile Idiopathic Arthritis Treatment Introduction
11.1.4 Johnson & Johnson Revenue in Juvenile Idiopathic Arthritis Treatment Business (2016-2021)
11.1.5 Johnson & Johnson Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Juvenile Idiopathic Arthritis Treatment Introduction
11.2.4 Novartis Revenue in Juvenile Idiopathic Arthritis Treatment Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Juvenile Idiopathic Arthritis Treatment Introduction
11.3.4 Bristol-Myers Squibb Revenue in Juvenile Idiopathic Arthritis Treatment Business (2016-2021)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Zydus Cadila
11.4.1 Zydus Cadila Company Details
11.4.2 Zydus Cadila Business Overview
11.4.3 Zydus Cadila Juvenile Idiopathic Arthritis Treatment Introduction
11.4.4 Zydus Cadila Revenue in Juvenile Idiopathic Arthritis Treatment Business (2016-2021)
11.4.5 Zydus Cadila Recent Development
11.5 Takeda
11.5.1 Takeda Company Details
11.5.2 Takeda Business Overview
11.5.3 Takeda Juvenile Idiopathic Arthritis Treatment Introduction
11.5.4 Takeda Revenue in Juvenile Idiopathic Arthritis Treatment Business (2016-2021)
11.5.5 Takeda Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Juvenile Idiopathic Arthritis Treatment Introduction
11.6.4 Roche Revenue in Juvenile Idiopathic Arthritis Treatment Business (2016-2021)
11.6.5 Roche Recent Development
11.7 Latona Life Sciences
11.7.1 Latona Life Sciences Company Details
11.7.2 Latona Life Sciences Business Overview
11.7.3 Latona Life Sciences Juvenile Idiopathic Arthritis Treatment Introduction
11.7.4 Latona Life Sciences Revenue in Juvenile Idiopathic Arthritis Treatment Business (2016-2021)
11.7.5 Latona Life Sciences Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Juvenile Idiopathic Arthritis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Surgical Treatment
Table 3. Key Players of Drug Treatment
Table 4. Global Juvenile Idiopathic Arthritis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Juvenile Idiopathic Arthritis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Juvenile Idiopathic Arthritis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Juvenile Idiopathic Arthritis Treatment Market Share by Regions (2016-2021)
Table 8. Global Juvenile Idiopathic Arthritis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Juvenile Idiopathic Arthritis Treatment Market Share by Regions (2022-2027)
Table 10. Juvenile Idiopathic Arthritis Treatment Market Trends
Table 11. Juvenile Idiopathic Arthritis Treatment Market Drivers
Table 12. Juvenile Idiopathic Arthritis Treatment Market Challenges
Table 13. Juvenile Idiopathic Arthritis Treatment Market Restraints
Table 14. Global Juvenile Idiopathic Arthritis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Juvenile Idiopathic Arthritis Treatment Market Share by Players (2016-2021)
Table 16. Global Top Juvenile Idiopathic Arthritis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Juvenile Idiopathic Arthritis Treatment as of 2020)
Table 17. Ranking of Global Top Juvenile Idiopathic Arthritis Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Juvenile Idiopathic Arthritis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Juvenile Idiopathic Arthritis Treatment Product Solution and Service
Table 21. Date of Enter into Juvenile Idiopathic Arthritis Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Juvenile Idiopathic Arthritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Juvenile Idiopathic Arthritis Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Juvenile Idiopathic Arthritis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Juvenile Idiopathic Arthritis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Juvenile Idiopathic Arthritis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Juvenile Idiopathic Arthritis Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Juvenile Idiopathic Arthritis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Juvenile Idiopathic Arthritis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Juvenile Idiopathic Arthritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Juvenile Idiopathic Arthritis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Juvenile Idiopathic Arthritis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Juvenile Idiopathic Arthritis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Juvenile Idiopathic Arthritis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Juvenile Idiopathic Arthritis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Juvenile Idiopathic Arthritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Juvenile Idiopathic Arthritis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Juvenile Idiopathic Arthritis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Juvenile Idiopathic Arthritis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Juvenile Idiopathic Arthritis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Juvenile Idiopathic Arthritis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Juvenile Idiopathic Arthritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Juvenile Idiopathic Arthritis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Juvenile Idiopathic Arthritis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Juvenile Idiopathic Arthritis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Juvenile Idiopathic Arthritis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Juvenile Idiopathic Arthritis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Juvenile Idiopathic Arthritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Juvenile Idiopathic Arthritis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Juvenile Idiopathic Arthritis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Juvenile Idiopathic Arthritis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Juvenile Idiopathic Arthritis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Juvenile Idiopathic Arthritis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Juvenile Idiopathic Arthritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Juvenile Idiopathic Arthritis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Juvenile Idiopathic Arthritis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Juvenile Idiopathic Arthritis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Juvenile Idiopathic Arthritis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Juvenile Idiopathic Arthritis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Johnson & Johnson Company Details
Table 62. Johnson & Johnson Business Overview
Table 63. Johnson & Johnson Juvenile Idiopathic Arthritis Treatment Product
Table 64. Johnson & Johnson Revenue in Juvenile Idiopathic Arthritis Treatment Business (2016-2021) & (US$ Million)
Table 65. Johnson & Johnson Recent Development
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis Juvenile Idiopathic Arthritis Treatment Product
Table 69. Novartis Revenue in Juvenile Idiopathic Arthritis Treatment Business (2016-2021) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Bristol-Myers Squibb Company Details
Table 72. Bristol-Myers Squibb Business Overview
Table 73. Bristol-Myers Squibb Juvenile Idiopathic Arthritis Treatment Product
Table 74. Bristol-Myers Squibb Revenue in Juvenile Idiopathic Arthritis Treatment Business (2016-2021) & (US$ Million)
Table 75. Bristol-Myers Squibb Recent Development
Table 76. Zydus Cadila Company Details
Table 77. Zydus Cadila Business Overview
Table 78. Zydus Cadila Juvenile Idiopathic Arthritis Treatment Product
Table 79. Zydus Cadila Revenue in Juvenile Idiopathic Arthritis Treatment Business (2016-2021) & (US$ Million)
Table 80. Zydus Cadila Recent Development
Table 81. Takeda Company Details
Table 82. Takeda Business Overview
Table 83. Takeda Juvenile Idiopathic Arthritis Treatment Product
Table 84. Takeda Revenue in Juvenile Idiopathic Arthritis Treatment Business (2016-2021) & (US$ Million)
Table 85. Takeda Recent Development
Table 86. Roche Company Details
Table 87. Roche Business Overview
Table 88. Roche Juvenile Idiopathic Arthritis Treatment Product
Table 89. Roche Revenue in Juvenile Idiopathic Arthritis Treatment Business (2016-2021) & (US$ Million)
Table 90. Roche Recent Development
Table 91. Latona Life Sciences Company Details
Table 92. Latona Life Sciences Business Overview
Table 93. Latona Life Sciences Juvenile Idiopathic Arthritis Treatment Product
Table 94. Latona Life Sciences Revenue in Juvenile Idiopathic Arthritis Treatment Business (2016-2021) & (US$ Million)
Table 95. Latona Life Sciences Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Juvenile Idiopathic Arthritis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Surgical Treatment Features
Figure 3. Drug Treatment Features
Figure 4. Global Juvenile Idiopathic Arthritis Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Diagnostic Laboratories Case Studies
Figure 8. Juvenile Idiopathic Arthritis Treatment Report Years Considered
Figure 9. Global Juvenile Idiopathic Arthritis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Juvenile Idiopathic Arthritis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Juvenile Idiopathic Arthritis Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Juvenile Idiopathic Arthritis Treatment Market Share by Regions (2022-2027)
Figure 13. Global Juvenile Idiopathic Arthritis Treatment Market Share by Players in 2020
Figure 14. Global Top Juvenile Idiopathic Arthritis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Juvenile Idiopathic Arthritis Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Juvenile Idiopathic Arthritis Treatment Revenue in 2020
Figure 16. Global Juvenile Idiopathic Arthritis Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Juvenile Idiopathic Arthritis Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Juvenile Idiopathic Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Juvenile Idiopathic Arthritis Treatment Market Share by Type (2016-2027)
Figure 20. North America Juvenile Idiopathic Arthritis Treatment Market Share by Application (2016-2027)
Figure 21. North America Juvenile Idiopathic Arthritis Treatment Market Share by Country (2016-2027)
Figure 22. United States Juvenile Idiopathic Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Juvenile Idiopathic Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Juvenile Idiopathic Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Juvenile Idiopathic Arthritis Treatment Market Share by Type (2016-2027)
Figure 26. Europe Juvenile Idiopathic Arthritis Treatment Market Share by Application (2016-2027)
Figure 27. Europe Juvenile Idiopathic Arthritis Treatment Market Share by Country (2016-2027)
Figure 28. Germany Juvenile Idiopathic Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Juvenile Idiopathic Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Juvenile Idiopathic Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Juvenile Idiopathic Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Juvenile Idiopathic Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Juvenile Idiopathic Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Juvenile Idiopathic Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Juvenile Idiopathic Arthritis Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Juvenile Idiopathic Arthritis Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Juvenile Idiopathic Arthritis Treatment Market Share by Region (2016-2027)
Figure 38. China Juvenile Idiopathic Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Juvenile Idiopathic Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Juvenile Idiopathic Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Juvenile Idiopathic Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Juvenile Idiopathic Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Juvenile Idiopathic Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Juvenile Idiopathic Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Juvenile Idiopathic Arthritis Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Juvenile Idiopathic Arthritis Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Juvenile Idiopathic Arthritis Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Juvenile Idiopathic Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Juvenile Idiopathic Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Juvenile Idiopathic Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Juvenile Idiopathic Arthritis Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Juvenile Idiopathic Arthritis Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Juvenile Idiopathic Arthritis Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Juvenile Idiopathic Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Juvenile Idiopathic Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Juvenile Idiopathic Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Johnson & Johnson Revenue Growth Rate in Juvenile Idiopathic Arthritis Treatment Business (2016-2021)
Figure 58. Novartis Revenue Growth Rate in Juvenile Idiopathic Arthritis Treatment Business (2016-2021)
Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Juvenile Idiopathic Arthritis Treatment Business (2016-2021)
Figure 60. Zydus Cadila Revenue Growth Rate in Juvenile Idiopathic Arthritis Treatment Business (2016-2021)
Figure 61. Takeda Revenue Growth Rate in Juvenile Idiopathic Arthritis Treatment Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in Juvenile Idiopathic Arthritis Treatment Business (2016-2021)
Figure 63. Latona Life Sciences Revenue Growth Rate in Juvenile Idiopathic Arthritis Treatment Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
世界の全身性特発性若年性関節炎治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Systemic Idiopathic Juvenile Arthritis Treatment Market The global Systemic Idiopathic Juvenile Arthritis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard ac…- 世界の若年性黄斑変性症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Juvenile Macular Degeneration Treatment Market The global Juvenile Macular Degeneration Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis…
- 世界の若年性黄斑変性症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Juvenile Macular Degeneration Treatment Market The global Juvenile Macular Degeneration Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis…
- 世界の特発性頭蓋内圧亢進症治療市場規模・現状・予測（2021年-2027年） Idiopathic intracranial hypertension is characterized by a buildup of the cerebrospinal fluid causing increase in the blood volume in vessels surrounding the brain and increase in brain swelling. The increase in salt intake causes water retention in the body together with fat adding on to the calori…
- 世界の関節リウマチ治療市場規模・現状・予測（2021年-2027年） Rheumatoid arthritis is a long-term autoimmune disorder that primarily affects joints. The rheumatoid arthritis treatment market is expected to grow over the forecast period owing to the high incidence rate of rheumatoid arthritis among people. Market Analysis and Insights: Global Rheumatoid Arthrit…